These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34073225)

  • 41. The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
    Crofford LJ; Nyhoff LE; Sheehan JH; Kendall PL
    Expert Rev Clin Immunol; 2016 Jul; 12(7):763-73. PubMed ID: 26864273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T; Rothstein TL
    J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nintedanib for the treatment of idiopathic pulmonary fibrosis.
    Varone F; Sgalla G; Iovene B; Bruni T; Richeldi L
    Expert Opin Pharmacother; 2018 Feb; 19(2):167-175. PubMed ID: 29327616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bruton's Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease.
    Neys SFH; Rip J; Hendriks RW; Corneth OBJ
    Drugs; 2021 Sep; 81(14):1605-1626. PubMed ID: 34609725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling.
    de Lavallade H; Khoder A; Hart M; Sarvaria A; Sekine T; Alsuliman A; Mielke S; Bazeos A; Stringaris K; Ali S; Milojkovic D; Foroni L; Chaidos A; Cooper N; Gabriel I; Apperley J; Belsey S; Flanagan RJ; Goldman J; Shpall EJ; Kelleher P; Marin D; Rezvani K
    Blood; 2013 Jul; 122(2):227-38. PubMed ID: 23719297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
    Middendorp S; Dingjan GM; Maas A; Dahlenborg K; Hendriks RW
    J Immunol; 2003 Dec; 171(11):5988-96. PubMed ID: 14634110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis.
    Grimminger F; Günther A; Vancheri C
    Eur Respir J; 2015 May; 45(5):1426-33. PubMed ID: 25745048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
    J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cgamma Src homology 2-Src homology 3 linker.
    Humphries LA; Dangelmaier C; Sommer K; Kipp K; Kato RM; Griffith N; Bakman I; Turk CW; Daniel JL; Rawlings DJ
    J Biol Chem; 2004 Sep; 279(36):37651-61. PubMed ID: 15184383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function.
    Kurosaki T; Kurosaki M
    J Biol Chem; 1997 Jun; 272(25):15595-8. PubMed ID: 9188445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
    Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
    Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Syk mediates BCR- and CD40-signaling integration during B cell activation.
    Ying H; Li Z; Yang L; Zhang J
    Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High SYK Expression Drives Constitutive Activation of CD21
    Keller B; Stumpf I; Strohmeier V; Usadel S; Verhoeyen E; Eibel H; Warnatz K
    J Immunol; 2017 Jun; 198(11):4285-4292. PubMed ID: 28468967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis.
    Asai Y; Chiba H; Nishikiori H; Kamekura R; Yabe H; Kondo S; Miyajima S; Shigehara K; Ichimiya S; Takahashi H
    Respir Res; 2019 Nov; 20(1):244. PubMed ID: 31694639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin.
    Kenny EF; Quinn SR; Doyle SL; Vink PM; van Eenennaam H; O'Neill LA
    PLoS One; 2013; 8(8):e74103. PubMed ID: 23967355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
    Wahl MI; Fluckiger AC; Kato RM; Park H; Witte ON; Rawlings DJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11526-33. PubMed ID: 9326643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bruton's tyrosine kinase regulates B cell antigen receptor-mediated JNK1 response through Rac1 and phospholipase C-gamma2 activation.
    Inabe K; Miyawaki T; Longnecker R; Matsukura H; Tsukada S; Kurosaki T
    FEBS Lett; 2002 Mar; 514(2-3):260-2. PubMed ID: 11943162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib.
    Bonella F; Stowasser S; Wollin L
    Drug Des Devel Ther; 2015; 9():6407-19. PubMed ID: 26715838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing.
    de Gorter DJ; Beuling EA; Kersseboom R; Middendorp S; van Gils JM; Hendriks RW; Pals ST; Spaargaren M
    Immunity; 2007 Jan; 26(1):93-104. PubMed ID: 17239630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.